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Abstract
Introduction
With improved access to antiretroviral therapy (ART), HIV infection is becoming a chronic ill-
ness. Preliminary data suggest that HIV-infected children have a higher risk of disabilities,
including hearing impairment, although data are sparse. This study aimed to estimate the
prevalence and types of hearing loss in HIV-infected children in Lilongwe, Malawi.
Methods
This was a cross-sectional survey of 380 HIV-infected children aged 4–14 years attending
ART clinic in Lilongwe between December 2013-March 2014. Data was collected through
pediatric quality of life and sociodemographic questionnaires, electronic medical record
review, and detailed audiologic testing. Hearing loss was defined as >20 decibels hearing
level (dBHL) in either ear. Predictors of hearing loss were explored by regression analysis
generating age- and sex-adjusted odds ratios. Children with significant hearing loss were fit-
ted with hearing aids.
Results
Of 380 patients, 24% had hearing loss: 82% conductive, 14% sensorineural, and 4%mixed.
Twenty-one patients (23% of those with hearing loss) were referred for hearing aid fitting.
There was a higher prevalence of hearing loss in children with history of frequent ear infec-
tions (OR 7.4, 4.2–13.0) and ear drainage (OR 6.4, 3.6–11.6). Hearing loss was linked to
history of WHO Stage 3 (OR 2.4, 1.2–4.5) or Stage 4 (OR 6.4, 2.7–15.2) and history of mal-
nutrition (OR 2.1, 1.3–3.5), but not to duration of ART or CD4. Only 40% of caregivers accu-
rately perceived their child’s hearing loss. Children with hearing impairment were less likely
to attend school and had poorer emotional (p = 0.02) and school functioning (p = 0.04).
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Conclusions
There is an urgent need for improved screening tools, identification and treatment of hearing
problems in HIV-infected children, as hearing loss was common in this group and affected
school functioning and quality of life. Clear strategies were identified for prevention and
treatment, since most hearing loss was conductive in nature, likely due to frequent ear infec-
tions, and many children with hearing loss qualified for hearing aids. Screening strategies
need to be developed and tested since caregivers were not reliable at identifying hearing
loss, and often mis-identified children with normal hearing as having hearing loss. Children
with frequent ear infections, ear drainage, TB, severe HIV disease, or low BMI should
receive more frequent ear assessments and hearing evaluations.
Introduction
HIV currently affects an estimated 35 million people worldwide. Over the past decade, quality
HIV care and access to ART has become much more widely available throughout Africa. The
expansion in access to ART globally has reduced HIV-related morbidity and mortality [1,2]
and contributed to an increase in life expectancy, including in low- income countries; in many
instances, it is now comparable to the general population [3]. As a consequence, HIV infection
is becoming a chronic illness [4,5]. As more HIV-infected patients are surviving, the magnitude
of a variety of disabilities has become more evident. These disabilities can result from the HIV
virus itself, opportunistic infections, or from medication side effects [4]. These disabilities can
further disadvantage children living with HIV, although the impact on their lives has rarely
been investigated.
One million of these HIV- infected patients live in Malawi, and 150,000 are children less
than 15 years of age [6]. Malawi has achieved a remarkably successful scale-up of HIV care and
treatment services. Whilst pediatric services initially lagged behind, in recent years there have
been great strides in expanding coverage for all children living with HIV. There are currently
around 42,525 children less than 15 years of age alive and on ART, representing nearly 9% of
all people on ART in Malawi [7].
To date, there are few studies looking at hearing loss in HIV-infected children, and many
have been small in size. All have found a high prevalence of hearing loss in HIV-infected chil-
dren, ranging between 6.4–84.8% [8–17], which is much higher when compared to general
population studies in children in these countries (4% in US, 6.9% in Peru) [8,10] or to unin-
fected controls (8.3% in South Africa) [13]. Hearing loss in HIV can arise from a variety of
causes, including recurrent otitis media, opportunistic infections such as cytomegalovirus
(CMV), tuberculosis (TB) or cryptococcus, syphilis, bacterial meningitis, or from side effects of
medications such as gentamicin or streptomycin [18]. Some research has even suggested that
some of the antiretroviral medications, such as certain nucleoside reverse transcriptase inhibi-
tors (NRTIs), may potentially lead to sensorineural hearing loss [19], although additional
research has suggested that antiretroviral medications do not result in hearing loss [20]. The
nature of the relationship between HIV and hearing loss, is therefore not yet clear, nor have
strategies for screening, prevention and treatment been outlined.
A recent study at the Baylor College of Medicine Clinical Centre of Excellence (BCOE) in
Lilongwe, Malawi reported higher prevalence of a range of disabilities in children living with
HIV when compared to their HIV-uninfected siblings [21]. Overall, 33% of HIV-infected
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children aged 2–9 years screened positive for a disability versus only 7% of their HIV-unin-
fected siblings; of the disabilities reported, 35% were hearing-related. Of the total patients par-
ticipating in the study, caregivers reported hearing difficulties in 12% of HIV-infected children,
compared with only 2% of their uninfected siblings. This current study was developed in
response to the high reports of hearing difficulties from the prior study, with the primary aim
to use audiologic assessments to assess the prevalence and types of hearing loss in HIV-infected
children attending the BCOE in Lilongwe, Malawi. Secondary aims included characterizing
clinical and sociodemographic factors associated with hearing loss in HIV-infected children, in
order to identify strategies for prevention and treatment, as well as assessment of the impact of
hearing loss on quality of life.
Materials and Methods
Ethical considerations
This study was reviewed and approved by both the Malawi National Health Sciences Research
Committee (NHSRC Protocol #1200) and the Baylor College of Medicine Institutional Review
Board (BCM Protocol H-33667). Full written informed consent was obtained from adult care-
givers, and assent was obtained from children 10 years and older unless they did not have ade-
quate cognitive ability to understand the study due to disability. Children who did not have
cognitive ability for assent were included in the study, as long as their caregiver provided
informed consent and a study clinician documented inability of the child to provide assent due
to cognitive delay. Participation in the study was entirely voluntary and confidential, and par-
ticipants were free to withdraw at any time without any consequences.
Study Design and Setting
This was a cross-sectional study conducted from December 2013 to March 2014.
Study Setting and Participants
Participants were HIV-infected children 4 to 14 years of age attending the Baylor College of
Medicine Children’s Clinical Center of Excellence (BCOE) in Lilongwe, Malawi. The BCOE in
Lilongwe serves as a tertiary referral center for pediatric HIV care and treatment, and has
approximately 3500 patients actively enrolled. This represents the largest cohort of pediatric
HIV-infected children in Malawi. While data are not available for all children participating in
the study, the vast majority of children attending care at BCOE are perinatally-infected. Partici-
pants were selected from a convenience sample of HIV-infected children aged 4 to 14 years
who were attending clinic at the BCOE and who were accompanied by their primary caregiver.
Caregiver report of hearing loss was not a criterion for enrollment. After informed consent was
completed, a research assistant completed two questionnaires with the caregiver and/or child.
Of the 380 participants, 93 children completed questionnaires. The children were then trans-
ported to African Bible College (ABC) Hearing Clinic and Training Centre, where trained
audiology staff performed extensive audiologic testing. ABC is a 5-minute drive from the
BCOE. On occasions when large numbers of older children were enrolled, a portable testing
van containing two soundproof booths was parked at BCOE and testing was done onsite. Fifty-
six children were tested using the audiotrailer. Younger children and children unable to be
assessed using age-appropriate subjective methods required the larger booths at ABC for play
audiometry, visual reinforcement audiometry (VRA), and other objective diagnostic assess-
ment equipment. Both the audiotrailer and the permanent audiobooths at ABC were custom
built in South Africa by the company Audiometry Specialists, using the same materials for the
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paneling. The audiotrailer was constructed to meet industrial hearing conservation program
standards for mobile testing units. The ambient noise levels of the audiotrailer are assessed
annually by an independent accredited calibrator from Johannesburg, using South African
Bureau of Standards (SABS) 0182/ 1998 maximum allowable noise measurements in dB of
sound pressure level (dBSPL). All relevant octave and interoctave frequency measures from
ambient noise from 125 Hz to 8KHz were under the maximum allowable limits. The diagnostic
audiometers in the audiotrailer were calibrated by the same technician who calibrates the audi-
ometers in the hearing clinic booths and measures the ambient noise levels of the audiotrailer.
Testing location was not included in statistical analysis.
Data Collection and Tools
Sociodemographic information was collected on age, gender, caregiver education, caregiver
HIV status, household size, household location, family income, source of water, asset owner-
ship, and food security. Information was also collected on school attendance and performance,
history of medical illnesses, and signs of hearing impairment. If a caregiver reported that they
believed their child had hearing impairment, an additional set of questions was asked concern-
ing the nature of the disability (severity, prior referrals, rehabilitation services, assistive devices,
and perceived barriers and challenges). The following HIV-related data were extracted from
the electronic medical records at BCOE on the date of the audiology testing: timing and dura-
tion of ART, CD4+ cell count, WHO status at enrollment, current WHO status, history of TB,
nutritional status, history of streptomycin exposure, documented history of hearing or ear
problems. All children on ART were on combination antiretroviral therapy (cART) with three
antiretroviral medications. Regimens were demarcated as non-nucleoside reverse transcriptase
inhibitor (NNRTI) or protease inhibitor (PI) based regimens. History of malnutrition was
determined by documented weight for height less than the 85th percentile as per the Ministry
of Health guidelines at the time of the study [22].
Caregivers completed the Caregiver version of the Pediatric Quality of Life Inventory
(PedsQL™), which has been translated into Chichewa and validated in Malawi [21]. The ques-
tionnaire contains items on physical functioning (8 questions), emotional functioning (5 ques-
tions), social functioning (5 questions), and school functioning (3–5 questions). Each question
was rated on a five-point scale from 0 (never a problem) to 4 (almost always a problem). Sepa-
rate questionnaires were used for children aged 4, 5–7, 8–12, and 13–14. Children aged 10 and
above completed the Child version of the PedsQL™ within the appropriate age category if they
had assented and were cognitively able to understand the questionnaire.
Trained audiology staff at ABC Hearing Clinic and Training Centre completed hearing
analysis on all children, including the following: otoscopy, tympanometry, transient evoked
otoacoustic emissions (TEOAE), and audiometry. The AccuScreen Pro was used for TEOAE
testing and uses a non-linear click sequence stimulus with click rate of approximately 60 Hz
and sampling rate of 16 kHz. The pass/refer criteria were evaluated according to AccuScreen
binomial statistics. The criterion level used by the AccuScreen Pro signal detection algorithm
for the presence of a time-locked signal is 99.7%. All audiometric assessment included in the
study was age-appropriate and performed under headphones. Pure-tone audiometry using a
button or hand-raise response was the preferred method. However, for those children aged 4–6
years, a play task was used to elicit the child’s response. If any cognitive impairment impacted
pure-tone or play testing, this was noted by the tester as an issue in preventing a reliable assess-
ment of hearing, and an alternative method was conducted. Eight children were unable to com-
plete pure-tone or play audiometry due to developmental delay; three of these children
successfully completed testing using VRA (also known as puppet in window testing) under
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headphones, and four children successfully completed VRA under freefield. One child required
auditory steady state testing under sedation due to severe neurocognitive impairment, with
stimulus presented through insert earphones. Audiometry testing was performed using an
Amplivox 240 Portable Diagnostic Audiometer at the following frequencies: 500, 1000, 2000,
3000, 4000, 8000 Hz. Bone conduction frequencies were tested at 500 Hz, 1000 Hz, 2000 Hz
and 4000 Hz. Pure tone average was used at four frequencies (500, 1000, 2000, and 4000 Hz) to
determine the average hearing threshold level. Hearing loss was defined as greater than 20 deci-
bels hearing level (dBHL) in either ear. Categories of hearing loss were defined as follows: nor-
mal (up to 20), mild (21–40), moderate (41–65), severe (66–90), and profound (91). The type
of hearing loss was determined based on the relationship of the four air and bone conduction
thresholds. If the bone conduction level was within 10dBHL of the air conduction level, the
hearing loss was considered to be sensorineural. If the bone conduction level was within the
normal range of hearing (20dBHL), then the hearing loss was conductive. If the bone con-
duction level was outside the normal range, but still better than the air-conduction threshold
by more than 10dBHL, then the hearing loss was considered to be mixed. Also, if the hearing
loss was clearly conductive at some frequencies and sensorineural at other frequencies, it was
considered mixed, based on the definition “a mixed hearing loss is the combination of a senso-
rineural loss and a conductive loss in the same ear” [23].
Children who qualified were fitted with hearing aids. Qualification for hearing aids was
determined by an audiologist and was based upon a combination of clinical and social criteria.
A bone conduction hearing aid was considered for children with a chronic and recent history
of discharging ears who had a mild to severe air conduction audiometric threshold average
(30–85 dBHL) in the better ear, and a normal or mild bone conduction audiometric threshold
average (35 dBHL). An air conduction hearing aid (behind the ear type), was considered for
children where their ear did not have ear discharge issues or other contraindications, but had a
mild to profound degree of hearing loss (average air conduction of30 to105 dBHL) which
was sensorineural, conductive, or mixed in nature. Hearing aid fitting was then discussed with
the child and guardian to ensure there was a recognized functional hearing loss requiring reha-
bilitation and that the device would be appropriately used and cared for.
Data Analysis
Age- and sex-adjusted odds ratios were generated through logistic regression to assess the rela-
tionship between the presence of hearing loss and HIV and sociodemographic characteristics.
For all analyses, the case definition was hearing loss greater than 20 dBHL in the worse ear. The
PedsQL™ were reverse-scored and linearly transformed to a 0–100 scale (0 = 100, 1 = 75, 2 = 25,
3 = 25, 4 = 0) with higher scores indicating better quality of life. Scale scores were computed as
the sum of the items divided by the number of items answered. If more than half the items were
missing data, then the scale score was not calculated. Age-sex-adjusted logistic regression analy-
ses were then completed to compare those with hearing loss versus no hearing loss.
Sensitivity of TEOAE as a screener for hearing loss was calculated by measuring the propor-
tion of people with hearing loss (as defined by audiometry) who did not pass the TEOAE test.
Specificity of TEOAE as a screener was calculated by measuring the proportion of people with-
out hearing loss (as defined by audiometry) who passed the TEOAE test.
Results
Prevalence of Hearing Loss
Of the 380 children aged 4 to 14 years recruited and tested, 90 (24%) patients had hearing loss
in either ear (mild 15%, moderate 5%, severe 2%, and profound 2%). Overall, 36 (9%) had an
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average hearing threshold of>20 dBHL in the better ear. Of the children with hearing loss in
either ear, 82% of the hearing loss was conductive, 14% was sensorineural, and 4% was mixed.
Degrees of hearing loss by type are included in Table 1. For the four children tested under free-
field, the ear-specific data included in the analyses was determined using results from the full
battery of tests as follows: one child had normal otoscopy, tympanometry, OAEs and VRA
with no reported history of hearing loss, so had presumed normal hearing for both ears.
Another child had all results consistent with bilateral middle ear pathology, with 40–60 dBHL
so a moderate conductive hearing loss was the most likely diagnosis for both ears. A third child
had mild hearing loss in freefield, likely to be the right ear, which had pass for OAE despite a
type B tympanogram indicative of middle ear effusion. The left ear was assumed to be a moder-
ate conductive loss due to a heavily discharging ear. The fourth child was later able to complete
VRA under headphones, and the results of this test were used in the analysis.
There is weak evidence that the sensorineural hearing loss is associated with more profound
levels of hearing loss, but it is difficult to make a clear statement given the small numbers.
Among children with hearing loss, 21 (23%) were referred for hearing aid fitting, 63% were not
recommended for hearing aid, and 14% were recommended to be reviewed at a later date.
Most children were fitted with bilateral hearing aids; children fitted with unilateral hearing aids
had either a very mild high frequency hearing loss in the non-fitted ear or an unaidable pro-
found hearing loss in the non-fitted ear.
Hearing characteristics (Table 2)
Most of the ears with conductive hearing loss had abnormal physical findings. For the 26 ears
with moderate or severe conductive hearing loss, 62% had perforated eardrums, 8% had an
Table 1. Degrees and Types of Hearing Loss in ears of HIV-infected children in Lilongwe, Malawi.
Degree of Hearing Loss (dBHL) Sensorineural Conductive Mixed
Mild (21–40) 6 (35%) 77 (75%) 1 (17%)
Moderate (41–65) 1 (6%) 24 (23%) 1 (17%)
Severe (66–90) 3 (18%) 2 (2%) 4 (67%)
Profound (91) 7 (41%) 0 (0%) 0 (0%)
Total* 17 103 6
*Data regarding type of hearing loss is missing for one ear
doi:10.1371/journal.pone.0161421.t001
Table 2. Relationship with hearing characteristics to hearing loss of the ears in children infected with HIV in Lilongwe, Malawi.
Ears with hearing loss
(n = 127)
Ears without hearing loss
(n = 633)
p-value
Tympanometry Normal 19 (16%) 499 (79%) <0.0001
Abnormal 98 (84%) 133 (21%)
Transient evoked otoacoustic emissions
(TEOAE)
Pass 25 (21%) 598 (95%) <0.0001
Refer 94 (79%) 31 (5%)
Otoscopy Wax 45 (35%) 149 (24%) 0.005
Discharge 31 (24%) 10 (2%) <0.001
Perforated 36 (28%) 12 (2%) <0.001
Fungi 6 (5%) 4 (1%) 0.0002
Red/bulging ear
drum
16 (13%) 6 (1%) <0.001
Ear drum abnormal 96 (76%) 142 (24%) <0.001
Ear drum not seen 23 (18%) 59 (9%) 0.004
doi:10.1371/journal.pone.0161421.t002
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acute otitis media with intact eardrum, 12% had a fungal infection, 38% had discharge, and
20% had more than one abnormal finding. A higher percentage of patients with hearing loss
had discharge in the external ear canal and perforated eardrum at the time of testing than those
patients without hearing loss. Other otoscopy findings such as ear canal inflammation, foreign
body, or dullness of eardrum were not related to hearing loss. All patients with otitis media, oti-
tis externa, fungal infections, effusions, or other medical issues were treated and re-evaluated at
a later date. Patients with discharge and perforation were also evaluated at a later date after the
physical exam findings had resolved for repeat testing. Presence of wax was defined if it was
obstructing or occluding the ear canal. The eardrum was more likely to be abnormal in those
patients with hearing loss. Only 16% of patient’s ears with hearing loss had normal tympano-
metry. The majority with abnormal tympanometry had no observable middle ear mobility for
compliance with normal canal volume (Bmid), indicating a middle ear effusion. In comparison,
79% of ears in patients without hearing loss had type A tympanometry, indicating normal
mobility and pressure. A higher percentage of ears in patients with hearing loss did not pass
the transient evoked otoacoustic emissions test (TEOAE) when compared with ears without
hearing loss. If OAE was used as the screening test for hearing loss, this would have 79% sensi-
tivity and 95% specificity.
Sociodemographic Factors (Table 3)
Mean age of all participants was 8.6 ± 3.2 years). Ages were similar in those with hearing loss
(mean age 8.5 ± 3.3 years) and those without hearing loss (mean age = 8.6 years ± 3.2 years).
There was no difference in age or gender comparing those with and without hearing loss. Chil-
dren with hearing loss tended to be more likely to report experiencing other disabilities.
Orphan status and current caregiver were not related to hearing loss. Children from families
with higher socioeconomic assets were less likely to have hearing loss than those from lower
socioeconomic status. Family income, location (urban vs. rural), food security, and parental
levels of education were not related to hearing loss.
Caregiver perception of hearing loss (Table 4)
Only 40% of caregivers of children with hearing loss accurately perceived the hearing loss,
though hearing impairment was related to caregiver perceived hearing loss. Of those with hear-
ing loss perceived by the caregiver, 67% had previously discussed the concern with a clinician.
Those with hearing loss were more likely to have had a hearing or ear problem noted in the
electronic medical record (EMR) and were more likely to have previously sought treatment.
Positive answers to caregiver screening questions were related to hearing loss, including need-
ing to repeat things to the child, the child having difficulty following instructions, and the child
not speaking clearly. Family history of hearing loss was not related to presence of hearing loss.
Among the children with perceived hearing loss, caregivers attributed this to unknown
causes (60%), illness (30%) and rarely to HIV (10%). Caregivers noted hearing loss at an aver-
age of 6.0 years (SD = 3.0 years). Among the children with hearing loss by audiometric testing,
only 7 (19%) had received a previous hearing test, and 3 of these children had already been fit-
ted with hearing aids prior to the study. Services sought for hearing loss included hospital
(25%), specialist clinic (22%), private doctor (6%) and other services (3%); the remaining chil-
dren had not sought any services.
Hearing Loss in relation to other health conditions (Table 5)
There was a higher prevalence of hearing loss in children with history of frequent ear infections
and ear drainage. History of TB treatment tended to be more common among children with
Hearing Loss in HIV-Infected Children in Lilongwe, Malawi
PLOS ONE | DOI:10.1371/journal.pone.0161421 August 23, 2016 7 / 14
Table 4. Caregiver Perception of Hearing Loss in HIV-Infected Children in Lilongwe, Malawi.
Hearing loss (n = 90) No hearing loss (n = 290) Age-sex adjusted OR (95% conﬁdence interval)
Perception of hearing loss Yes 36 (40%) 31 (11%) 5.9 (3.3–10.6)
No 54 (60%) 259 (89%) Baseline
If yes, discussed with clinician Yes 24 (67%) 10 (32%) 4.6 (1.6–13.6)
No 12 (33%) 21 (68%) Baseline
Need to repeat for child to understand Yes 37 (41%) 68 (23%) 5.0 (3.0–8.4)
No 53 (59%) 222 (77%) Baseline
Difﬁculty following instructions Yes 27 (30%) 48 (17%) 2.2 (1.3–3.9)
No 63 (70%) 242 (83%) Baseline
Child speaks clearly Yes 68 (76%) 261 (90%) Baseline
No 22 (24%) 29 (10%) 2.9 (1.6–5.5)
Family history of hearing loss Yes 15 (17%) 28 (10%) 1.8 (0.9–3.6)
No 75 (83%) 262 (90%) Baseline
Sought treatment for hearing loss Yes 16 (18%) 9 (3%) 7.5 (3.1–18.1)
No 74 (82%) 281 (97%) Baseline
Hearing problem noted in EMR Yes 55 (61%) 111 (38%) 2.7 (1.6–4.4)
No 35 (39%) 179 (62%) Baseline
doi:10.1371/journal.pone.0161421.t004
Table 3. Sociodemographic Factors of HIV-infected Children in Lilongwe, Malawi in Relation to Hearing Loss.
Hearing loss (n = 90) No hearing loss (n = 290) Age-sex-adjusted OR (95% conﬁdence interval)
Age 4 13 (15%) 34 (12%) Baseline
5–7 36 (41%) 124 (43%) 1.3 (0.6–2.8)
8–12 25 (28%) 83 (29%) 1.3 (0.6–2.8)
13–14 14 (16%) 46 (16%) 1.3 (0.5–3.0)
Gender Male 44 (49%) 145 (50%) Baseline
Female 46 (51%) 145 (50%) 1.0 (0.6–1.5)
Parental Status One or both parents dead 32 (36%) 86 (30%) 1.4 (0.8–2.4)
Both parents alive 58 (64%) 204 (70%) Baseline
Other disabilities Yes 17 (19%) 31 (11%) 1.8 (1.0–3.5)
No 73 (81%) 259 (89%) Baseline
Socioeconomic Status
Asset Score Low 53 (59%) 144 (50%) Baseline
Medium 28 (31%) 78 (27%) 3.1 (1.4–7.0)
High 9 (10%) 68 (23%) 3.1 (1.3–7.3)
Education of father None/Primary 35 (44%) 84 (30%) 1.5 (0.9–2.5)
Secondary+ 45 (56%) 193 (70%) Baseline
Education of Mother None/Primary 45 (51%) 132 (46%) 1.2 (0.7–1.9)
Secondary+ 43 (49%) 155 (54%) Baseline
Family income Low 29 (43%) 109 (46%) Baseline
Medium 24 (36%) 73 (31%) 1.3 (0.7–2.4)
High 14 (21%) 56 (23%) 0.9 (0.4–1.8)
Location Rural 34 (38%) 123 (42%) Baseline
Urban 42 (47%) 126 (44%) 1.2 (0.7–2.1)
Peri-urban 14 (15%) 41 (14%) 1.2 (0.6–2.5)
Food security High 18 (20%) 67 (23%) Baseline
Medium 38 (42%) 115 (40%) 1.3 (0.7–2.5)
Low 34 (38%) 108 (37%) 1.2 (0.6–2.3)
doi:10.1371/journal.pone.0161421.t003
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hearing loss; only 4 children with hearing loss had been exposed to the ototoxic medication
streptomycin as part of their TB treatment. Place of birth, history of overnight admissions,
recent outpatient treatment for an illness, history of meningitis, and current body mass index
(BMI) were not related to hearing loss.
Hearing Loss in relation to HIV characteristics (Table 6)
Almost all children with hearing loss (98%) were on ART, and average duration was 4.6 years.
There was no significant difference between the age of entry into care, the age of ART
Table 5. Hearing Loss in Relation to Other Health Conditions in HIV-infected Children in Lilongwe, Malawi.
Hearing loss
(n = 90)
No hearing loss
(n = 290)
Age-sex adjusted OR (95% conﬁdence
interval)
Place of birth Hospital 61 (68%) 170 (59%) 1.1 (0.5–2.7)
Health
clinic
21 (23%) 93 (33%) 0.7 (0.3–1.8)
Home 8 (9%) 24 (8%) Baseline
History of overnight admission Yes 74 (82%) 228 (79%) 1.3 (0.7–2.4)
No 16 (18%) 62 (21%) Baseline
Recent outpatient treatment for illness (<2
months)
Yes 13 (14%) 29 (10%) 1.5 (0.7–3.1)
No 77 (86%) 261 (90%) Baseline
Meningitis Yes 6 (7%) 17 (6%) 1.2 (0.5–3.2)
No 84 (93%) 273 (94%) Baseline
Frequent ear infections Yes 42 (47%) 31 (11%) 7.4 (4.2–13.0)
No 48 (53%) 259 (89%) Baseline
Ear drainage Yes 35 (39%) 27 (9%) 6.4 (3.6–11.6)
No 55 (61%) 263 (91%) Baseline
TB treatment Yes 43 (48%) 105 (36%) 1.7 (1.0–2.7)
No 47 (52%) 185 (64%) Baseline
BMI (body mass index) BMI<16 54 (60%) 185 (64%) 0.8 (0.5–1.4)
BMI> = 16 36 (40%) 105 (36%) Baseline
doi:10.1371/journal.pone.0161421.t005
Table 6. Hearing Loss in relation to HIV characteristics among children in Lilongwe, Malawi.
Hearing loss (n = 90) No hearing loss (n = 290) Age-sex adjusted OR (95% conﬁdence interval)
On ART Yes 88 (98%) 268 (92%) 3.8 (0.9–16.4)
No 2 (2%) 22 (8%) Baseline
If yes, duration of ART 4.6 (2.2) 4.7 (2.1) P = 0.67
If yes, age at ART initiation 4.0 (3.2) 3.9 (3.5) P = 0.72
WHO stage at enrolment 1 15 (17%) 98 (34%) Baseline
2 13 (14%) 44 (15%) 2.1 (0.9–4.8)
3 44 (49%) 129 (44%) 2.4 (1.2–4.5)
4 18 (20%) 19 (7%) 6.4 (2.7–15.2)
Current WHO stage 1 84 (93%) 281 (97%) Baseline
2+ 6 (7%) 9 (3%) 2.2 (0.7–6.4)
Nadir CD4 476 (373) 482 (355) P = 0.57
Nadir CD4<200 Yes 19 (22%) 61 (21%) 1.1 (0.6–2.0)
No 67 (78%) 223 (79%) Baseline
Current CD4 935 (510) 935 (499) P = 0.79
Age entering into care 3.9 (3.4) 3.6 (3.4) P = 0.19
History of malnutrition recorded in EMR Yes 48 (53%) 101 (35%) 2.1 (1.3–3.5)
No 42 (47%) 189 (65%) Baseline
doi:10.1371/journal.pone.0161421.t006
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initiation, or duration of ART in children with and without hearing loss. Children with hearing
loss were more likely to have been WHO Stage 3 or Stage 4 at enrollment in clinic, rather than
Stage 1. Current WHO Stage, and current or nadir CD4<200 were not related to hearing
impairment. For those with any degree of malnutrition recorded in the EMR, there was a
higher association with hearing loss. Various ART regimens were not significantly different
between children with and without hearing loss.
Impact of hearing loss on lives of HIV-infected children (Table 7)
Among children above 5 years, those with hearing loss tended to be less likely to be attending
school. However, if the child was attending school, hearing loss did not seem to affect whether
they were in the correct class at school for their age or their school performance. For those chil-
dren not attending school, lack of money was the main factor (35%), while lack of transport
(23%) and child too sick (19%) were other major factors; the remaining did not identify the
reason. Children with hearing loss reported poorer emotional and school functioning, but not
poorer overall quality of life, physical health or social functioning.
Discussion
The overall prevalence of hearing loss in any ear among children with HIV in this study was
24%, and was largely conductive in nature. Overall, 5.5% of all children tested required a hear-
ing aid, almost one in four of those with hearing loss. Few of the children with hearing loss had
previously undergone audiometry or had been referred for relevant services. Factors signifi-
cantly associated with hearing loss included WHO Stage 3 or 4 at enrollment, perceived hear-
ing loss by caregiver, documentation of hearing or ear problems in the medical record, history
of frequent ear infections or ear drainage, and positive screens for reported signs of hearing
impairment. Children with HIV and hearing loss were more likely to report other disabilities,
less likely to attend school, and had poorer emotional and school functioning.
Most previous studies have reported the prevalence of hearing loss among children living
with HIV to be 20–30% [8–13,16], and so our findings are within this range. Other studies
have reported a higher prevalence of hearing loss among children living with HIV than our
estimates [14,17], potentially because the participants in our study were generally healthier, for
Table 7. Impact of hearing loss on the lives of children with HIV in Lilongwe, Malawi (age >5).
Hearing loss (n = 90) No hearing loss (n = 290) Age-sex adjusted OR (95% conﬁdence interval)
Attending school Never 10 (13%) 16 (6%) 2.5 (1.0–6.0)
Sometimes 8 (11%) 25 (10%) 1.2 (0.5–2.8)
Always 57 (76%) 212 (84%) Baseline
If yes, school year correct for age No 29 (45%) 97 (41%) Baseline
Yes 36 (55%) 140 (59%) 0.9 (0.5–1.6)
Grades (school performance) Below average 12 (18%) 42 (18%) 1.0 (0.4–2.1)
Average 28 (43%) 107 (45%) 0.9 (0.5–1.7)
Above average 25 (39%) 88 (37%) Baseline
Quality of life p-value
Total score 48.4 (42.2) 49.4 (43.6) 0.33
Physical health 81.4 (19.4) 85.3 (17.8) 0.09
Emotional functioning 82.8 (15.6) 86.8 (13.0) 0.02
Social functioning 91.1 (17.5) 92.8 (12.8) 0.32
School functioning 72.3 (19.1) 77.2 (16.2) 0.04
doi:10.1371/journal.pone.0161421.t007
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instance with a low proportion of patients with WHO Stage III/IV. Furthermore, the BCOE is
a tertiary health center with more resources than most health centers in Malawi, including
equipment for testing hearing (e.g. otoscopes), and a consistent supply of oral and topical anti-
biotics to treat acute otitis media and chronic suppurative otitis media.
When reviewing clinical factors associated with hearing loss in HIV-infected children, we
found that hearing loss was more likely in those with more severe illness at enrollment (WHO
Stage 3 or 4), similar to other studies where hearing loss was more common in children with
history of AIDS-defining illnesses [8]. Our findings that current disease status (ie: WHO Stage)
and nadir CD4 were not found to be statistically significant supports previous findings [8].
Predominant types of hearing loss in HIV-infected children have varied across studies, with
several studies reporting the majority with conductive hearing loss [10,16], as in this study,
while others studies reported higher prevalence of sensorineural hearing loss [8,9,15] or central
auditory disorders [14]. The high prevalence of conductive hearing loss in this and other stud-
ies was likely due to high rates of ear infections, as we saw high rates of middle ear abnormali-
ties, such as perforated tympanic membranes.
This study shows a large unmet need for ear examination and hearing services among chil-
dren living with HIV in Malawi. This finding is concerning, especially given that the vast
majority of children were already benefiting from ART and therefore in regular contact with
health care professionals. Caregivers were unreliable at perceiving hearing loss: only 40% of
caregivers of children with hearing loss accurately perceived the hearing loss, while 11% of chil-
dren with no hearing loss were reported by their caregiver to have difficulties hearing. One pos-
sible explanation may be that the definition of hearing loss used in this study (>20 dB HL in
either ear), resulting in a lack of recognition of hearing loss in one ear. Possible explanations
for over-reporting of hearing loss in children with normal audiologic exams may be due to the
fluctuating nature of conductive hearing loss, where previous conductive hearing loss has
resolved. Additionally, there is likely to be high prevalence of cognitive and developmental
delay [24,25] and central auditory processing disorders [14] among these children, and caregiv-
ers may therefore have found it difficult to distinguish between these disorders and hearing
loss, resulting in higher caregiver report of hearing loss in children with normal audiologic test-
ing. These findings imply that parents are not sufficiently reliable judges to allow the identifica-
tion and referral of children with hearing loss for services. Routine screening for all HIV-
infected children with OAE would detect a high proportion of the ears with hearing loss, and is
now possible at relatively low cost by non-specialists with widely available mobile phone tech-
nology. Alternatively, hearing loss screening questions could be developed to detect those at
high risk for hearing loss so that they can be referred for ear exam and hearing evaluation (e.g.
those with perceived hearing impairment, frequent ear infections, ear drainage, TB, more
severe HIV or a low BMI), although this study showed that screening questions alone missed
many children with hearing loss, and a better screening tool for hearing loss needs to be devel-
oped. Education regarding ear health and hearing loss in HIV-infected children is needed for
both clinicians as well as patients and their caregivers.
In our patients, the high prevalence of conductive hearing loss and high frequency of dis-
charging ears and abnormal tympanic membranes suggest recurrent or chronic otitis as a likely
cause of hearing loss. This finding implies that preventive services could focus on the early
identification and treatment of ear infections in these children, and different models of devel-
oping this intervention should be considered. Furthermore, many of the children with hearing
loss could benefit from hearing aids, indicating another point for intervention. Studies are
needed to develop screening strategies for hearing loss among children with HIV, as well as
prevention and treatment services.
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Hearing loss related to HIV was demonstrated to impact school attendance and aspects of
quality of life, which has not been described previously, and further contributes towards the
disadvantages experienced by children with HIV. These impacts may be ameliorated through
the provision of hearing aids. Other interventions may also be needed to ensure that children
with hearing loss can participate fully in school, such as training of teachers or linking the chil-
dren with hearing loss to community-based rehabilitation programmes.
Strengths of this study include a large sample size, with comprehensive assessments of the
ears and hearing completed for every child. A broad range of data was collected through the elec-
tronic medical record, patient and caregiver interviews, and formal audiologic assessment. Limi-
tations of this study include lack of an HIV-negative control group. However, data on children in
Africa show that the expected prevalence of hearing loss is far lower than that identified in this
study [26]. Another limitation is the lack of consistency in the definition of hearing loss. While
the World Health Organization (WHO) recommends 25dB or greater as the criteria for hearing
loss [27], studies commissioned through the WHO have used 20dB as the cutoff [26], and 20dB
is widely considered among audiologists as the cutoff for normal hearing. Furthermore, several
studies of hearing loss in HIV-infected children have even used 15dB as the cutoff [13,16–17].
Therefore, comparison of prevalence among studies can be difficult when different cutoffs are
used. The prevalence of hearing loss was lower than expected, so the study was underpowered
for some responses, such as CD4<200. There were only 36 children with hearing loss> 20
dBHL in the better ear, so additional analyses of this subset of children would not have been sta-
tistically robust. As our patient population attends care at a tertiary health facility, results may
not be representative of all HIV-infected children in Malawi; therefore, further testing needs to
done in more typical health centers in Malawi. Exposure to ototoxic medications such as quinine
and gentamicin was not included in the analysis, as these medications are usually given in the
inpatient setting and are thus not regularly recorded in the clinic EMR. Etiologies of hearing loss
were unable to be determined due to limitations in diagnostic testing for diseases such as cyto-
megalovirus (CMV), so history of such illnesses was unable to be included in the study.
Conclusions
There is an urgent need for improved screening tools, identification and treatment of hearing
problems in HIV-infected children, as hearing loss was common in this group and affected
school functioning and quality of life. Clear strategies were identified for prevention and treat-
ment, since most hearing loss was conductive in nature, likely due to frequent ear infections,
and many children with hearing loss qualified for hearing aids. Screening strategies need to be
developed and tested, since caregivers were not reliable at identifying hearing loss, and often
mis-identified children with normal hearing as having hearing loss. Children with frequent ear
infections, ear drainage, TB, severe HIV disease, or low BMI should receive more frequent ear
assessments and hearing evaluations.
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